why choose us

First received: June 12, 2023

Clinical Trial: A Study of Safety and Drug Levels of HIB210 in Healthy Volunteers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Immune System Diseases

Study Type: INTERVENTIONAL


Official Title: Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HIB210 in Healthy Volunteers

Brief Summary: The goal of this clinical trial is to test safety of the investigational product in healthy volunteers.The main questions it aims to answer is when HIB210 is administered as multiple doses, is it:SafeWell toleratedDoes the body absorb and eliminate HIB210 as expected

Read more